Abraxane approved to treat advanced lung cancer
(HealthDay)—Abraxane (paclitaxel protein-bound) has been approved by the U.S. Food and Drug Administration—in combination with the drug carboplatin—to treat advanced or spreading non-small cell lung ...
Cancer
Oct 14, 2012 |
not rated yet |
0
Calls for more US oversight after tainted drug outbreak
A deadly meningitis outbreak in the United States blamed on a tainted drug has triggered outrage and calls for tighter regulation of the loosely controlled pharmaceutical compounding industry.
Medications
Oct 11, 2012 |
not rated yet |
0
Parent-clinician communication about children's drug reactions needs improvement
Many parents are dissatisfied with communication regarding adverse drug reactions experienced by their child, and the implications of such reactions for the child's future use of medicines, according to a new study published ...
Health
Oct 10, 2012 |
not rated yet |
0
Profs aim to track drug reactions via social media
Experiencing nausea, headaches or other side effects from prescriptions or over-the-counter medicines? Researchers say tweeting about it or posting your concerns online could one day help alert drug companies and federal ...
Medications
Oct 03, 2012 |
not rated yet |
0
Hopes that new substance will induce cancer cell suicide
(Medical Xpress)—The p53 gene plays a key role in the prevention of cancer, by blocking cell growth and triggering programmed cell death or apoptosis. If, however, p53 has mutated and become defective, the cancer cells ...
Cancer
Sep 18, 2012 |
not rated yet |
0
|
Aubagio approved for multiple sclerosis
(HealthDay)—Aubagio (teriflunomide) has been approved by the U.S. Food and Drug Administration to treat adults with relapsing forms of multiple sclerosis (MS).
Medications
Sep 13, 2012 |
not rated yet |
0
Evaluate children's stress after natural disasters
As Hurricane Isaac nears the Gulf Coast, one may wonder what the impact of natural disasters are on children. Who is most at risk for persistent stress reactions? How can such youth be identified and assisted in the aftermath ...
Psychology & Psychiatry
Aug 28, 2012 |
not rated yet |
0
Study shows efficacy of new rheumatoid arthritis drug
(Medical Xpress) -- A new study involving researchers from Karolinska Institutet demonstrates the efficacy of Tofacitinib, a new drug for rheumatoid arthritis. According to the study, which is published in The New England ...
Arthritis & Rheumatism
Aug 09, 2012 |
not rated yet |
0
Kyprolis approved for multiple myeloma
(HealthDay) -- Kyprolis (carfilzomib) has been approved by the U.S. Food and Drug Administration to treat certain people with multiple myeloma who have already been given at least two prior therapies.
Cancer
Jul 20, 2012 |
not rated yet |
0
Roche probed over faulty drug-safety reporting
Swiss pharmaceutical giant Roche is under investigation over a failure to properly report adverse drug side-effects, the European Medicines Agency (EMA) said on Thursday.
Medications
Jun 21, 2012 |
4 / 5 (1) |
0
Changes needed for oft-ignored prescription warning labels
Each year, an estimated four million Americans experience adverse reactions to prescription medications. Many of these reactions, ranging from mild rashes and drowsiness to hospitalization and death, could ...
Health
Jun 15, 2012 |
not rated yet |
1
New discovery could lead to new way to screen drugs for adverse reactions
Adverse drug reactions are a major issue that cause harm, are costly and restrict treatment options for patients and the development of new drugs. A groundbreaking finding by researchers from the La Jolla Institute for Allergy ...
Immunology
May 29, 2012 |
5 / 5 (3) |
0
|
Internet and new drugs: A challenge for public health
A group of researchers from the IMIM (Hospital del Mar Research Institute) and from the INAD (Hospital del Mar Neuropsychiatry and Addictions Institute) has participated in an international study aiming to give a general ...
Health
May 08, 2012 |
not rated yet |
0
ICD-9 codes underestimate statin-linked rhabdomyolysis
(HealthDay) -- Use of diagnostic codes, such as International Classification of Diseases -- Ninth Revision (ICD-9) codes, may result in misclassification of rare, adverse drug reactions (ADRs), including the ...
Medications
Apr 18, 2012 |
not rated yet |
0
Prescribing opioids for pain after short-stay surgery appears associated with long-term use
Prescribing opioids for pain to older patients within seven days of short-stay surgery appears to be associated with long-term analgesic use compared to those patients who did not receive prescriptions for analgesics after ...
Medications
Mar 12, 2012 |
not rated yet |
0
